Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
MODY Unmasked: How Genetics Is Redefining Diabetes Treatment
Genetics is rewriting the rules of diabetes care. In this episode, we explore how Maturity-Onset Diabetes of the Young (MODY) challenges traditional treatment models — from groundbreaking gene discoveries to the rise of precision therapies tailored to each patient’s unique profile.
Bibliography
- Müssig K. Novel treatment options in maturity-onset diabetes of the young. Exp Clin Endocrinol Diabetes. 2025;133(1):51–58. doi:10.1055/a-2436-7723
- Laver TW, Patel KA. MODY and beyond: the changing face of single-gene diabetes. Eur J Endocrinol. 2025;193(3):R25–R29. doi:10.1093/ejendo/lvaf172
- Mazloum A et al. MODY10: genetics, clinical features, and therapeutic advances. Int J Mol Sci. 2025;26(16):8110. doi:10.3390/ijms26168110
- Geng HY, Wang ZH. Research advances in maturity-onset diabetes of the young. Zhongguo Dang Dai Er Ke Za Zhi. 2025;27(1):121–126. doi:10.7499/j.issn.1008-8830.2408070
- Ługowski F et al. Pregnancy and neonatal outcomes in MODY: systematic review. Int J Mol Sci. 2025;26(13):6057. doi:10.3390/ijms26136057
- Dzhemileva LU et al. Etiology, diagnosis, epidemiology, and gene therapy in MODY. Front Endocrinol (Lausanne). 2025;15:1497298. doi:10.3389/fendo.2024.1497298
- Bombonato M et al. SGLT2 inhibitors in MODY: case report and literature review. Hormones (Athens). 2025;24(2):495–498. doi:10.1007/s42000-025-00632-8
- Nie D, Lou X. Novel glucokinase mutation causing MODY: case report. Br J Hosp Med (Lond). 2025;86(6):1–11. doi:10.12968/hmed.2024.1056
- Ba T et al. NEUROD1-MODY prevalence and clinical characteristics in Chinese early-onset T2DM. J Diabetes. 2025;17(4):e70080. doi:10.1111/1753-0407.70080
- Fontana P et al. MODY5 and 17q12 microdeletion syndrome: phenotype variability and counseling. Genes (Basel). 2025;16(9):1002. doi:10.3390/genes16091002
